Edwards Lifesciences (EW) Tops Q4 EPS by 3c; Raises Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. SMCI
8. RTX
9. S
10. COF

Go back to Edwards Lifesciences (EW) Tops Q4 EPS by 3c; Raises Outlook

Edwards Lifesciences (EW) PT Raised to $150 at BMO Capital

February 2, 2018 8:21 AM EST

BMO Capital raised its price target on Edwards Lifesciences (NYSE: EW) to $150.00 (from $145.00) while maintaining a Outperform rating.

... More

Edwards Lifesciences (EW) PT Raised to $174 at Canaccord Genuity

February 2, 2018 7:08 AM EST

Canaccord Genuity raised its price target on Edwards Lifesciences (NYSE: EW) to $174.00 (from $140.00) while maintaining a Buy rating. An analysis suggests the stock should trade to at least $174 by year-end, based solely on the fundamentals currently evident in the business, let alone... More

Edwards Lifesciences (EW) PT Raised to $138 at Morgan Stanley

February 2, 2018 6:55 AM EST

Morgan Stanley raised its price target on Edwards Lifesciences (NYSE: EW) to $138.00 (from $130.00) while maintaining a Overweight rating.

... More

Edwards Lifesciences (EW) PT Raised to $155 at Barclays

February 2, 2018 4:34 AM EST

Barclays raised its price target on Edwards Lifesciences (NYSE: EW) to $155.00 (from $135.00) while maintaining a Overweight rating.

... More

Edwards Lifesciences (EW) PT Raised to $140 at JMP Securities

February 2, 2018 4:16 AM EST

JMP Securities raised its price target on Edwards Lifesciences (NYSE: EW) to $140.00 (from $135.00) while maintaining a Market Outperform rating.

... More